Ac immune to participate in upcoming virtual investor conferences in september

Lausanne, switzerland, sept. 02, 2021 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in the following upcoming virtual investor conferences:
ACIU Ratings Summary
ACIU Quant Ranking